Gossamer Bio, Inc. (GOSS) stock

GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30

$10.97−0.27 (-2.40%)

Close on Nov 13, 2026Market cap $67.10MP/E –Yield –

Gossamer Bio EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Gossamer Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Gossamer Bio's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-80 reverse split on Sep 11, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing